A new, not yet peer-reviewed
study conducted in Israel has found that the Pfizer vaccine might not offer sufficient protection against the South African variants of the coronavirus. These variants are known as B.1.1.7 and B.1.351. Researchers said they saw signs that these variants could “break through” vaccination protection.